|
22 Jan 2020 |
Targovax Announces Encouraging Data in Mesothelioma Study Combining ONCOS-102 and Standard of Care Chemotherapy
|
|
22 Jan 2020 |
FDA Approves TEPEZZA (TM) (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)
|
|
22 Jan 2020 |
PDC*line Pharma raises €20 million in Series B financing round
|
|
21 Jan 2020 |
Biotech start-up Seekyo raises €800k with leverage from French Tech Seed Fund
|
|
21 Jan 2020 |
BeiGene Announces that the Phase 3 Clinical Trial of its Anti-PD-1 Antibody Tislelizumab in Patients with First-Line Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis
|
|
21 Jan 2020 |
Rafael Pharmaceuticals Announces the Initiation of a Phase 1b/2 Clinical Trial of CPI-613 (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer
|
|
21 Jan 2020 |
Stealth BioTherapeutics Initiates First-in-Human Study of SBT-272
|
|
21 Jan 2020 |
Clene Nanomedicine Announces First Patient Dosed in the RESCUE-ALS Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8
|
|
21 Jan 2020 |
Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 INVIGORATE Trial in Allergic Conjunctivitis
|
|
21 Jan 2020 |
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
|
|
21 Jan 2020 |
Anokion Announces FDA Clearance of IND Application for its Lead Program in Celiac Disease
|
|
21 Jan 2020 |
US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma
|
|
21 Jan 2020 |
Abivax Receives Clearance from U.S. FDA to Initiate Clinical Trials with ABX464 to treat Moderate to Severe Ulcerative Colitis
|
|
21 Jan 2020 |
European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma
|
|
21 Jan 2020 |
Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody
|
|
21 Jan 2020 |
Polaryx Therapeutics Receives IND Approval for PLX-200 From the FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis
|
|
21 Jan 2020 |
Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
|
|
21 Jan 2020 |
PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
|
|
21 Jan 2020 |
European Commission Approves Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible
|
|
21 Jan 2020 |
Novartis announces EU approval of Mayzent® (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease
|
